Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Mona DossK L Hartshorn

Abstract

θ-Defensins are cyclic octadecapeptides found in nonhuman primates whose broad antiviral spectrum includes HIV-1, HSV-1, severe acute respiratory syndrome coronavirus, and influenza A virus (IAV). We previously reported that synthetic θ-defensins called retrocyclins can neutralize and aggregate various strains of IAV and increase IAV uptake by neutrophils. This study describes two families of peptides, hapivirins and diprovirins, whose design was inspired by retrocyclins. The goal was to develop smaller partially cyclic peptides that retain the antiviral activity of retrocyclins, while being easier to synthesize. The novel peptides also allowed for systemic substitution of key residues to evaluate the role of charge or hydrophobicity on antiviral activity. Seventy-two hapivirin or diprovirin peptides are described in this work, including several whose anti-IAV activity equals or exceeds that of normal α- or θ-defensins. Some of these also had strong antibacterial and antifungal activity. These new peptides were active against H3N2 and H1N1 strains of IAV. Structural features imparting strong antiviral activity were identified through iterative cycles of synthesis and testing. Our findings show the importance of hydrophobic resi...Continue Reading

References

Mar 1, 1990·International Journal of Peptide and Protein Research·G B Fields, R L Noble
Dec 1, 1986·Journal of Virology·K A DaherR I Lehrer
Jul 1, 1994·The Journal of Clinical Investigation·K L HartshornK Sastry
Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M R WhiteK L Hartshorn
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexander M ColeRobert I Lehrer
Jan 9, 2003·JAMA : the Journal of the American Medical Association·David M Morens
May 29, 2003·Current Pharmaceutical Design·Alexander M Cole, Robert I Lehrer
Jan 1, 1959·The Journal of Clinical Investigation·D B LOURIAD E ROGERS
Mar 17, 2004·Peptides·Tung X NguyenRobert I Lehrer
Sep 17, 2004·Nature Reviews. Microbiology·Robert I Lehrer
Sep 13, 2005·Nature Immunology·Eugenia LeikinaLeonid V Chernomordik
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevan L HartshornErika C Crouch
Dec 14, 2006·The Journal of Infectious Diseases·Adolfo Garcia-Sastre, Richard J Whitley
Dec 22, 2006·Journal of Virology·Kristy J SzretterJacqueline M Katz
Aug 10, 2007·Biochemistry·Norelle L DalyDavid J Craik
Aug 19, 2007·The Journal of Infectious Diseases·Mirella SalvatoreMary E Klotman
Aug 28, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Mitchell R WhiteKevan L Hartshorn
Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kaifeng Lisa LinMichael Dee Gunn
Apr 17, 2008·Accounts of Chemical Research·John A Robinson
Jun 7, 2008·Annals of Emergency Medicine·Alexander J KallenJeffrey Hageman
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mitchell WhiteKevan Hartshorn
May 1, 2009·PLoS Biology·Nitya VenkataramanAlexander M Cole
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mona DossKevan L Hartshorn
Jul 1, 2008·Expert Review of Clinical Immunology·Mitchell R WhiteKevan L Hartshorn
Oct 8, 2009·Journal of Leukocyte Biology·Mona DossKevan L Hartshorn
Nov 27, 2009·Biotechnology Letters·Qing-long LiangHong-xuan He
Apr 27, 2010·Innate Immunity·Tesfaldet TecleKevan L Hartshorn

❮ Previous
Next ❯

Citations

May 8, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Emily Gwyer FindlayDonald J Davidson
Sep 15, 2012·BMC Medicine·Sailen Barik
Mar 8, 2013·Future Medicinal Chemistry·Derry K Mercer, Deborah A O'Neil
Nov 13, 2013·Innate Immunity·Shweta TripathiKevan L Hartshorn
Dec 23, 2016·Chemical Biology & Drug Design·Paulina StrzeleckaAdam Lesner
May 19, 2017·FEMS Microbiology Reviews·María Eugenia Pachón-IbáñezJavier Sánchez-Céspedes
Aug 1, 2014·Angewandte Chemie·Anne C Conibear, David J Craik
Nov 28, 2013·Current Opinion in Hematology·Le Zhao, Wuyuan Lu
Dec 2, 2015·The Journal of Biological Chemistry·Sriram AmbadapadiAlexandra Lucas
Jul 19, 2017·Annual Review of Virology·Mayumi K HollyJason G Smith
Mar 27, 2013·Organic & Biomolecular Chemistry·Kendall G BylerKarina Martinez-Mayorga
Jul 4, 2015·Innate Immunity·Marloes HoeksemaKevan L Hartshorn
Feb 29, 2020·Nature Reviews. Drug Discovery·Neeloffer MookherjeeDonald J Davidson
Jan 14, 2021·Scientific Reports·Song Hee LeeJoshy Jacob
Nov 17, 2020·Frontiers in Cellular and Infection Microbiology·Kevan L Hartshorn
Nov 19, 2020·Journal of Leukocyte Biology·Mitchell R WhiteKevan L Hartshorn
May 3, 2021·Microbial Pathogenesis·Subhash Singh SolankiSyed Azmal Ali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

© 2022 Meta ULC. All rights reserved